VALUE OF TELEMONITORING FOR POSITIVE AIRWAY PRESSURE THERAPY MANAGEMENT IN OBSTRUCTIVE SLEEP APNEA: A SYSTEMATIC LITERATURE REVIEW
Author(s)
Ankit Ghildiyal, MSc1, Melike Deger, MSc2, Kate Cole, MSc3, Anoushka Pathak, MSc4, Khushbu Baranwal, MPharm4, Fatima Sert, PhD3, Raju Gautam, PhD5.
1ResMed Science Center, Didcot, Oxforshire, United Kingdom, 2ResMed Science Center, Munich, Germany, 3ResMed Science Center, San Diego, CA, USA, 4ConnectHEOR, Delhi, India, 5ConnectHEOR, London, United Kingdom.
1ResMed Science Center, Didcot, Oxforshire, United Kingdom, 2ResMed Science Center, Munich, Germany, 3ResMed Science Center, San Diego, CA, USA, 4ConnectHEOR, Delhi, India, 5ConnectHEOR, London, United Kingdom.
OBJECTIVES: Obstructive sleep apnea (OSA) is associated with substantial healthcare utilization and costs. Positive airway pressure (PAP) therapy is the standard treatment for OSA, and telemonitoring has emerged as a strategy to support patient management. This systematic literature review (SLR) summarized evidence on PAP adherence, symptom control, and economic outcomes associated with telemonitoring and telemedicine-based PAP management in adults with OSA.
METHODS: A SLR was conducted in Embase and PubMed on 06 October 2025 following Cochrane Handbook and PRISMA guidelines. Searches included peer-reviewed publications from January 2005 onward and conference abstracts from January 2023 onward evaluating telemonitoring or telemedicine-based PAP management in adults with OSA. Data on PAP adherence, symptom control, and economic outcomes were extracted and synthesized.
RESULTS: Of 1,422 records screened, 114 underwent full-text review, and 12 studies met the inclusion criteria, comprising eight trial-based economic evaluations, one model-based analysis, and three healthcare costs and resource utilization studies conducted across Spain (n=4), China (n=2), the United States (n=2), and Sweden (n=1), the United Kingdom (n=1), and Australia (n=1). Seven studies reported clinically non-inferiority of remote management regarding PAP adherence and symptom control compared to standard in-person care. Economic findings were generally favorable: ten studies reported telemonitoring to be cost-effective or cost-saving, while two did not demonstrate cost-effectiveness. Reported economic benefits were primarily driven by reduced patient travel and more efficient use of healthcare resources.
CONCLUSIONS: These findings suggest that telemonitoring and telemedicine-based management of PAP achieves adherence and symptoms outcomes comparable to traditional in-person care. Differences in economic findings likely reflect variation in healthcare settings and analytic time horizons, with longer-term analyses generally demonstrating greater economic value. Overall, telemonitoring represents a promising strategy to improve efficiency of OSA management while maintaining treatment effectiveness.
METHODS: A SLR was conducted in Embase and PubMed on 06 October 2025 following Cochrane Handbook and PRISMA guidelines. Searches included peer-reviewed publications from January 2005 onward and conference abstracts from January 2023 onward evaluating telemonitoring or telemedicine-based PAP management in adults with OSA. Data on PAP adherence, symptom control, and economic outcomes were extracted and synthesized.
RESULTS: Of 1,422 records screened, 114 underwent full-text review, and 12 studies met the inclusion criteria, comprising eight trial-based economic evaluations, one model-based analysis, and three healthcare costs and resource utilization studies conducted across Spain (n=4), China (n=2), the United States (n=2), and Sweden (n=1), the United Kingdom (n=1), and Australia (n=1). Seven studies reported clinically non-inferiority of remote management regarding PAP adherence and symptom control compared to standard in-person care. Economic findings were generally favorable: ten studies reported telemonitoring to be cost-effective or cost-saving, while two did not demonstrate cost-effectiveness. Reported economic benefits were primarily driven by reduced patient travel and more efficient use of healthcare resources.
CONCLUSIONS: These findings suggest that telemonitoring and telemedicine-based management of PAP achieves adherence and symptoms outcomes comparable to traditional in-person care. Differences in economic findings likely reflect variation in healthcare settings and analytic time horizons, with longer-term analyses generally demonstrating greater economic value. Overall, telemonitoring represents a promising strategy to improve efficiency of OSA management while maintaining treatment effectiveness.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
MT3
Topic
Economic Evaluation, Medical Technologies, Study Approaches